Rebekka Rolfsnes: new PhD student in the group

MSc Rebekka Rolfsnes, an employee of the Norwegian start-up biotech company Adjutec Pharma, started her PhD with us the first of April 2022. We are glad to have Rebekka back in the group after she did her MSc thesis with us in 2020 on bacterial fish vaccines. Rebekka will do her PhD on the project entitled: The novel antimicrobial resistance breaker APC247 – studies on mechanism of action (MoA) and resistance development to a putative dual SBL/MBL inhibitor. The project is funded by the Norwegian Research Council.